By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Inotek Pharmaceuticals Corporation 

100 Cummings Center, Suite 419E

Beverly  Massachusetts  01915  U.S.A.
Phone: 978-232-9660 Fax: 978-232-8975


SEARCH JOBS


Industry
Pharmaceutical






Company News
Inotek Pharmaceuticals Corporation Brings In A New President And CEO 8/13/2014 7:44:02 AM
Inotek Pharmaceuticals Corporation Announces Study Results Demonstrating Neuroprotective Properties Of Trabodenoson, Its Lead Drug Candidate For Glaucoma 5/30/2014 9:27:52 AM
Inotek Pharmaceuticals Corporation Initiates Phase 2 Study With Trabodenoson In Combination With Latanoprost For Patients With Glaucoma Or Ocular Hypertension 3/10/2014 8:37:15 AM
Inotek Pharmaceuticals Corporation Collects $21 Million for Development of Glaucoma Drug 9/27/2013 6:49:14 AM
Inotek Pharmaceuticals Corporation Presents Positive Phase 2 Data of Trabodenoson in Glaucoma 11/8/2012 10:06:05 AM
Inotek Pharmaceuticals Corporation to Present Phase 2 Data of Trabodenoson in Glaucoma at the Ophthalmology Innovation Summit 11/2/2012 8:34:08 AM
Inotek Pharmaceuticals Corporation to Expand Phase 2 Clinical Trial in Glaucoma Based on Promising Preliminary Results 7/21/2011 10:25:48 AM
Inotek Pharmaceuticals Corporation Initiates Multiple-Dose Phase 2 Clinical Trial of INO-8875 in Patients With Glaucoma 6/17/2010 9:40:28 AM
Inotek Pharmaceuticals Corporation Brings In $18M For Eye Treatments 6/11/2010 8:30:19 AM
Inotek Pharmaceuticals Corporation Presents Preclinical Data at ARVO Confirming That INO-8875 Lowers IOP by Increasing Outflow Through the Trabecular Meshwork 5/4/2010 11:54:54 AM
12345
//-->